To Increase Patient Access

Post Category: Glioblastoma

October 14, 2023
Living with Recurrent Glioblastoma

Patients and caregivers dealing with first recurrence glioblastoma are being sought for an important survey. Make your voice heard.

Read More
September 7, 2023
rGBM Patients Encouraged to Share Their Experience

Jenn Ortiz, a two-time brain tumor survivor, describes her participation in the Patient Reported Outcomes rGBM study.

Read More
September 6, 2023
Gleolan Tumor Imaging Agent

Gleolan Brain Dye, imaging agent, helps neurosurgeons to see “high grade gliomas” during surgery. Learn about Gleolan.

Read More
September 6, 2023
More Great News For The Fight Against GBM!

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

Read More
July 8, 2023
rGBM Study: Share Your Experience and Shape Future Treatments for GBM

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

Read More
July 7, 2023
Recruiting Now for Patients with Recurrent GBM

We are looking to interview patients, and their caregivers, who are living with recurrent glioblastoma (GBM).

Read More
June 29, 2023
Glioblastoma Symptoms: How to Spot the Signs of This Deadly Brain Cancer Tumor

Glioblastoma overview with a description of the symptoms of this treatment-resistant brain cancer.

Read More
June 22, 2023
2023 Hope Award Runner Up

Jennifer Ortiz Is the 1st runner-up recipient of the 2023 EBCI National HOPE Award.

Read More
June 8, 2023
How Kiyatec’s 3D Predict™ Directs Cancer Care

Thanks to Kiyatec’s 3D Predict, cancer patients with elevated HCG levels and their physicians are seeing game-changing results.

Read More
May 17, 2023
Imvax Immunotherapy Clinical Study

Imvax is conducting a new phase 2b clinical study, with a combination immunotherapy, for newly diagnosed patients with glioblastoma.

Read More
May 16, 2023
Building Resilience through Gratitude & Self Care

The Pacific Neuroscience Institute has created a series of videos featuring patients and caregivers discussing brain tumor treatments.

Read More
April 13, 2023
Recruiting Now for Patients with Recurrent GBM

If you have been diagnosed with rGBM (first recurrence only), would you like to participate in a PAID short interview?

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram